Cerebras Systems Inc. (NASDAQ:CBRS - Get Free Report) CAO Yagnesh Patel sold 4,574 shares of the firm's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $222.22, for a total value of $1,016,434.28. Following the completion of the sale, the chief accounting officer directly owned 16,676 shares of the company's stock, valued at approximately $3,705,740.72. This trade represents a 21.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Yagnesh Patel also recently made the following trade(s):
- On Thursday, June 25th, Yagnesh Patel sold 6,079 shares of Cerebras Systems stock. The stock was sold at an average price of $171.53, for a total value of $1,042,730.87.
- On Friday, June 26th, Yagnesh Patel sold 3,954 shares of Cerebras Systems stock. The shares were sold at an average price of $174.03, for a total transaction of $688,114.62.
- On Thursday, June 25th, Yagnesh Patel sold 46 shares of Cerebras Systems stock. The stock was sold at an average price of $189.36, for a total value of $8,710.56.
Cerebras Systems Price Performance
Shares of Cerebras Systems stock traded down $5.84 during trading on Thursday, hitting $209.85. 6,684,719 shares of the stock traded hands, compared to its average volume of 7,543,250. The business's fifty day moving average is $208.60. Cerebras Systems Inc. has a twelve month low of $160.81 and a twelve month high of $386.34.
Cerebras Systems (NASDAQ:CBRS - Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The company reported ($2.98) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($2.77). The company had revenue of $209.87 million for the quarter. The company's quarterly revenue was up 74.3% compared to the same quarter last year. As a group, equities research analysts predict that Cerebras Systems Inc. will post -0.52 earnings per share for the current year.
Key Cerebras Systems News
Here are the key news stories impacting Cerebras Systems this week:
- Positive Sentiment: Cerebras and Callosum announced a partnership to deliver ultra-low-latency, heterogeneous AI inference for agentic applications. The agreement strengthens Cerebras’ position in real-time AI workloads and could expand its commercial reach if customers adopt the combined offering. Cerebras and Callosum partnership
- Positive Sentiment: The company’s CS-4 rack-scale accelerator is being promoted as up to 30 times faster than GPU-based solutions for certain inference workloads. The launch supports Cerebras’ strategy of competing with Nvidia in fast, real-time AI processing. Cerebras CS-4 announcement
- Positive Sentiment: Rosenblatt Securities and Needham reaffirmed “buy” ratings with $300 price targets. Unusually heavy call-option activity and reports of manufacturing expansion, a large backlog, and potential growth in AI inference are also supporting bullish interest.
- Neutral Sentiment: The CS-4 speed advantage is primarily a company claim and must be validated through independent benchmarks, customer deployments, and sustained sales. The technology announcement may therefore boost sentiment before materially affecting financial results.
- Negative Sentiment: CEO Andrew Feldman sold 26,644 shares worth approximately $5.9 million to cover tax withholding tied to vested equity awards. Although the stated reason reduces its significance, the sale cut his ownership by 28.5%. Cerebras CEO insider sale
- Negative Sentiment: Director Eric Vishria sold about $15.7 million of stock, while director Steven Vassallo sold approximately $10.9 million. The transactions, even where conducted under trading plans, may reinforce profit-taking concerns.
- Negative Sentiment: Cerebras recently reported a $2.98-per-share loss versus the expected $0.21 loss, despite 74.3% year-over-year revenue growth to $209.9 million. The sharp earnings miss keeps profitability and valuation as important risks for CBRS.
Analysts Set New Price Targets
CBRS has been the topic of a number of recent research reports. TD Cowen initiated coverage on shares of Cerebras Systems in a report on Monday, June 8th. They set a "buy" rating and a $275.00 price target on the stock. Rosenblatt Securities reissued a "buy" rating and set a $300.00 target price on shares of Cerebras Systems in a research report on Wednesday. Weiss Ratings started coverage on Cerebras Systems in a report on Thursday, August 13th. They set a "sell (d)" rating on the stock. Wall Street Zen raised Cerebras Systems from a "sell" rating to a "hold" rating in a research report on Saturday, August 15th. Finally, UBS Group upped their price target on Cerebras Systems from $320.00 to $330.00 and gave the stock a "buy" rating in a research note on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $299.90.
Read Our Latest Stock Analysis on Cerebras Systems
Institutional Trading of Cerebras Systems
Institutional investors have recently modified their holdings of the company. Wellington Management Group LLP acquired a new stake in Cerebras Systems during the second quarter worth $194,853,000. Montanova Capital LLC bought a new stake in Cerebras Systems in the second quarter valued at about $37,990,000. Bank of New York Mellon Corp acquired a new position in Cerebras Systems in the second quarter worth about $6,118,000. Ratan Capital Management LP acquired a new stake in Cerebras Systems during the second quarter valued at approximately $4,641,000. Finally, Proficio Capital Partners LLC acquired a new position in shares of Cerebras Systems in the 2nd quarter worth approximately $1,383,000.
Cerebras Systems Company Profile
(
Get Free Report)
Cerebras Systems is a technology company focused on building artificial intelligence infrastructure, including hardware and software designed to accelerate deep learning and large-scale AI workloads. The company is best known for its wafer-scale processor architecture, which is intended to provide high-performance compute for training and inference applications.
In addition to its AI chips, Cerebras offers systems and related software tools that support researchers and enterprises working with machine learning models.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cerebras Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cerebras Systems wasn't on the list.
While Cerebras Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.